{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Use of .alpha..sub.1C specific compounds to treat benign prostatic hyperlasia", "item": "https://www.patentleaderboard.com/patent/5403847"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of .alpha..sub.1C specific compounds to treat benign prostatic hyperlasia

Use of .alpha..sub.1C specific compounds to treat benign prostatic hyperlasia

US Patent 5403847 · Granted Apr 4, 1995

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau2025
Quinazolinones that inhibit the formation of tau oligomers and their method of u2022
Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau2022
Substituted pyrazole kinase inhibitors2009
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders2009
Substituted [4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-urea compounds2009
Piperazinyl substituted cyclohexane-1,4-diamines2009
Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof2009
Piperidinyl substituted cyclohexane-1,4-diamines2008
Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds 2008
Substituted isoindole-1,3-diones2008
Spirocyclic piperidines as MCH1 antagonists and uses thereof2008